急诊治疗重症心力衰竭的临床效果分析

The Clinical Effects of the Emergency Treatment of Severe Heart Failure Analysis

目的分析急诊治疗重症的心力衰竭效果。方法回顾性分析2014年3月至2015年3月本院收治的急诊重症的心力衰竭89例患者临床资料,根据不同治疗方案分为两组,对照组行常规治疗,研究组在对照组基础上行美托洛尔与厄贝沙坦氢氯噻嗪联合方案,分析两组各项指标及临床疗效。结果研究组患者各项指标在治疗前后变化明显,且相比对照组降低幅度大(P<0.05);且研究组的总有效率为86.96%,对照组的总有效率为58.14%,研究组临床治疗效果明显优于对照组,差异比较具统计学意义(P<0.05)。结论急诊治疗重症心力衰竭时,配合美托洛尔联合厄贝沙坦氢氯噻嗪治疗,能有效提高临床效果,疗效显著。

Objective Analysis of the effect of the emergency treatment of severe heart failure. Methods A retrospective analysis from March 2014 to March 2015 our hospital emergency department with severe heart failure clinical data of 89 patients, depending on the treatment program is divided into two groups, the control group underwent conventional treatment, study Group on the basis of the control group use metoprolol irbesartan and hydrochlorothiazide joint program, analyze two of the indicators and clinical efficacy. Results Study patients before and after treatment indexes changed significantly reduced compared to the control group and the amplitude（P 0.05）; and the total effective rate of 86.96% of the study group, the control group total effective rate 58.14%, clinical research group treatment is better than the control group, the difference was statistically significant comparison（P〈0.05）. Conclusion When the emergency treatment of severe heart failure, with metoprolol irbesartan Hydrochlorothiazide therapy, can effectively improve the clinical results, a significant effect.